Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

New generation of substrates to harness the full power of microorganisms

Project description

Advanced substrates to revolutionise bio-based industries

Microbiology plays a vital role in bio-based industries and research, offering critical insights and advancements across multiple sectors. Many industries rely on cultivating microbes, yet growing complex microbial communities outside their natural habitat remains a significant challenge. This difficulty, particularly in human mucus layers, hampers microbiology-based technologies. Developers of microbiome-modulating drugs and microbiome researchers require a platform that supports microbial growth under biologically relevant conditions. The EIC-funded Bac3Gel project aims to create innovative in-vitro mucus models that enable the cultivation of complex communities. By integrating a three-dimensional structure with nutrient gradients, physical properties, and oxygen distribution, the project will develop a ready-to-use platform for developing microbiota-based therapies. This breakthrough will advance microbiome research and unlock new therapeutic possibilities.

Objective

Bac3Gel is a biotech company that develops and distributes advanced substrates to harness the full power of microorganisms.
Bac3Gel substrates are the first that combine three-dimensionality with gradients of oxygen, nutrients and physical properties to allow the growth of complex microbial communities and currently unculturable bacteria that depend on these microenvironments to thrive. Our advanced substrates have the power to revolutionise the status quo of microbiology and unlock innovative bacteria-based solutions to solve challenges across multiple bio-based industries. Bac3Gel mission is to ultimately foster the discovery of new antibiotics and bio-based solutions to feed the ever-growing demand for innovative treatments, as well as the development of microbiome-modulating drugs to address 90% of diseases linked to human microbiome imbalance.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2023-ACCELERATOR-01

See all projects funded under this call

Coordinator

BAC3GEL, LDA.
Net EU contribution
€ 1 500 712,00
Address
EDIFICIO INOVACAO II, TAGUSPARK, AV
2740-122 Porto Salvo
Portugal
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 2 143 875,00